The Role of Selective Multidetector Computed Tomography After a Transcatheter Aortic Valve Implant

Marco Moscarelli1,2, Philippe Pibarot3, Nicolas Van Mieghem4

  • 1Department of Surgery and Cancer-Faculty of Medicine London, Imperial College, United Kingdom.

Insights

Transcatheter aortic valve implantation (TAVI) requires long-term monitoring for prosthetic valve durability. Multimodality imaging, including computed tomography, can detect subclinical leaflet thrombosis and guide personalized surveillance after TAVI.

Area of Science:

  • Cardiovascular Imaging
  • Prosthetic Valve Performance
  • Interventional Cardiology

Background:

  • Transcatheter aortic valve implantation (TAVI) is increasingly used in younger, lower-risk patients, necessitating focus on long-term prosthetic valve durability.
  • Transthoracic echocardiography, while standard, may not detect early structural or geometric abnormalities like subclinical leaflet thrombosis.
  • Subclinical leaflet thrombosis, characterized by hypoattenuated leaflet thickening and reduced motion, can precede overt valve dysfunction.

Purpose of the Study:

  • To review the role of multimodality imaging in identifying thrombogenic valve phenotypes after TAVI.
  • To propose an integrated imaging framework for post-TAVI surveillance and management.

Main Methods:

  • Review of current literature on TAVI, prosthetic valve durability, and imaging modalities.
  • Analysis of how prosthesis geometry influences neo-sinus flow and thrombotic substrate formation.
  • Integration of transthoracic echocardiography and multidetector computed tomography (MDCT) for comprehensive assessment.

Main Results:

  • Prosthesis geometry (e.g., under-expansion, ellipticity, misalignment) can alter flow and promote thrombosis.
  • Multidetector computed tomography (MDCT) allows integrated assessment of leaflet morphology, thrombus, and prosthetic geometry.
  • Subclinical leaflet thrombosis is a dynamic phenomenon linked to mechanical factors.

Conclusions:

  • Multimodality imaging is crucial for understanding mechanical determinants of thrombosis after TAVI.
  • An integrated imaging approach combining echocardiography and selective MDCT can support individualized post-TAVI surveillance.
  • Early detection of thrombogenic valve phenotypes may optimize patient management and improve long-term outcomes.

Related Concept Videos

Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...